Manuel Acosta-De
Santiago De Compostela, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-Line Therapy in Anti-Tumor Necrosis Factor-Experienced Patients With Ulcerative Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 07, 2025
Multicenter Spanish study on vedolizumab intravenous to subcutaneous switch in patients with inflammatory bowel disease in clinical remission.
Journal: Revista espanola de enfermedades digestivas
Published: September 29, 2025
Effectiveness and safety of dual advanced therapy in inflammatory bowel disease: a multicenter series from Galicia, Spain.
Journal: Revista espanola de enfermedades digestivas
Published: September 29, 2025
Multicenter Spanish study on vedolizumab intravenous to subcutaneous switch in patients with inflammatory bowel disease in clinical remission.
Journal: Revista espanola de enfermedades digestivas
Published: September 29, 2025
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective.
Journal: United European gastroenterology journal
Published: July 05, 2024
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort.
Journal: Scandinavian journal of gastroenterology
Published: November 07, 2023
Association between vitamin D and inflammatory bowel diseases
Journal: Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
Published: October 27, 2023
Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies' Determination against ELISA.
Journal: Pharmaceutics
Published: October 04, 2023
The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU.
Journal: Inflammatory bowel diseases
Published: August 28, 2023
Health-related quality of life by IBDQ-32 in colombian patients with inflammatory bowel disease in remission: A cross-sectional study
Journal: Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
Published: August 19, 2023
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).
Journal: Journal of clinical medicine
Published: September 18, 2022
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.
Journal: Journal of clinical medicine
Published: December 09, 2021
Last Updated: 09/26/2026